Why the study?
Current evidence regarding IABP use after the IABP-SHOCK II trial is ambiguous, and its hemodynamic impact in Asian Indian patients presenting with ACS and cardiogenic shock was unknown.
Does Intra-Aortic Balloon pump (IABP) improve hemodynamics in Asian Indian patients with Acute Coronary Syndrome with cardiogenic Shock?
Population
60 Asian Indian patients with ACS and CS
Comparison
IABP support vs no IABP support
Design
Open-label prospective randomized trial
Follow-up
24 hours
Authors
Loading...
IABP confers no hemodynamic benefit in ACS cardiogenic shock; does not support routine use and leaves open questions on inotrope reduction.
Does Intra-Aortic Balloon pump (IABP) improve hemodynamics in Asian Indian patients with Acute Coronary Syndrome with cardiogenic Shock?
The use of IABP in Asian Indian patients with ACS and cardiogenic shock did not improve hemodynamic parameters, although it reduced the required dose of dobutamine.
Sharma et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: